Top Ten No. (1) Sequenom v. Ariosa: From the standpoint of the law of patent-eligibility under 35 USC §101, this is a most important case. The petition is now due ...
Further to the note earlier today (attached below), this morning the Court denied petitions for certiorari in ePlus and Arthrex. TopTenCases2016Feb29 Regards Hal
In Samsung v. Apple, the Supreme Court is scheduled to vote this Friday whether to grant certiorari in a design patent infringement case where the first Question Presented asks: “Where ...
As the April 1st certiorari deadline approaches in Sequenom, Inc. v. Ariosa Diagnostics, Inc., Supreme Court No. 15A871, the underlying facts seemingly compel industry amici support to make sure that the ...
Section 101 patent-eligibility for biotechnology and pharmaceuticals stands at a critical junction: At some point in April 2016 amici briefs in support of the petition forcertiorari in the Sequenom case ...
Today in Apple, Inc. v. Samsung Electronics, Inc., __ F.3d __ (Fed. Cir. 2016)(Dyk, J.), in a case involving claims of infringement by each party against the other and where ...
Last week in The Ohio Willow Wood Co. v. Alps South, LLC, __ F.3d __ (Fed. Cir. Feb. 19, 2016)(Bryson, J.), the panel affirmed an inequitable ruling based upon a ...
Responsive to the publication of the original SEQUENOM WHITE PAPER, several colleagues have pointed to uncertainties in the patent law with the idea thatcertiorari should be granted in such cases ...
According to the ABA Journal[FN*], the captioned acquisition reported February 17th (appended below) has been consumated. The article reports that “[t]hose joining Polsinelli include top management at Novak Druce, which ...
Col. Reynolds was a registered patent attorney who had a long and distinguished military career lasting 28 years until his retirement in 1970 after which he practiced law. He was ...